American Shared Hospital Services (NYSE American: AMS), a leading provider of stereotactic radiosurgery equipment and advanced radiation therapy cancer treatment services, announced today that it will hold a conference call to discuss its first quarter 2026 financial results on May 14th at 12:00 pm ET. The earnings press release will be issued before the market opens on the same day, offering transparency into the company's recent financial performance.
The call is significant for investors and industry observers as it will provide updates on the company's operations, including its equipment leasing and direct patient care services segments. American Shared Hospital Services has been expanding its footprint in the cancer treatment market, particularly in Gamma Knife, proton therapy, and advanced radiation therapy services. The earnings call will likely shed light on the progress of these initiatives and the company's financial health.
To participate in the teleconference, domestic callers can dial 1-844-413-3972, and international callers can dial 1-412-317-5776 at least ten minutes before the start time. A simultaneous webcast of the call will be available through the company's website at www.ashs.com or directly via this webcast link. A replay will be accessible from May 14th through May 21st by calling 1-855-669-9658 or 1-412-317-0088, access code 6753554. The replay will also be archived on the company's website.
American Shared Hospital Services provides turnkey solutions to cancer treatment centers, health systems, and cancer networks across North and South America. The company collaborates with partners to develop and expand cancer service lines, sharing capital investment costs and profitability based on ownership interests. This model aims to deliver integrated cancer care in local settings, making treatment more accessible to patients.
Forward-looking statements in the press release highlight potential risks and uncertainties, including economic conditions, compliance with debt covenants, variability of financial results, changes in CMS reimbursement rates, and the integration of acquired businesses. Investors are encouraged to review the company's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2025, for a detailed discussion of risk factors.
The earnings call provides an opportunity for stakeholders to assess the company's trajectory in the competitive cancer treatment market. With the aging population and increasing incidence of cancer, the demand for advanced radiation therapy and radiosurgery is expected to grow, positioning American Shared Hospital Services to capitalize on these trends. The company's focus on partnership models and expansion into new markets could be key drivers of future growth, making the upcoming financial results highly anticipated.
